InsideArbitrage Event Driven Monitor – December 13, 2024
Merger Arbitrage
- LUMO: The acquisition of Lumos Pharma (LUMO) by Double Point Ventures LLC was completed on December 12, 2024. It took 50 days for the deal to be completed.
- RVNC: Crown Laboratories commenced the tender offer to acquire Revance Therapeutics (RVNC). The offer is expected to expire on January 13, 2025.
- MKFG: Markforged (MKFG) announced that on November 20, 2024, and December 12, 2024, it received clearances from the applicable foreign direct investment (FDI) authorities in Sweden and the United Kingdom, respectively. The CFIUS approval is still pending.
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
